KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Cost of Revenue (2016 - 2025)

Incyte (INCY) has disclosed Cost of Revenue for 16 consecutive years, with $121.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 36.94% year-over-year to $121.2 million, compared with a TTM value of $372.1 million through Dec 2025, up 19.25%, and an annual FY2025 reading of $372.1 million, up 19.25% over the prior year.
  • Cost of Revenue was $121.2 million for Q4 2025 at Incyte, up from $99.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $121.2 million in Q4 2025 and bottomed at $29.2 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $64.9 million, with a median of $60.5 million recorded in 2023.
  • The sharpest move saw Cost of Revenue soared 45.84% in 2022, then rose 2.78% in 2025.
  • Year by year, Cost of Revenue stood at $43.9 million in 2021, then skyrocketed by 34.85% to $59.2 million in 2022, then rose by 17.9% to $69.8 million in 2023, then rose by 26.86% to $88.5 million in 2024, then soared by 36.94% to $121.2 million in 2025.
  • Business Quant data shows Cost of Revenue for INCY at $121.2 million in Q4 2025, $99.0 million in Q3 2025, and $78.8 million in Q2 2025.